In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices
2007

Metabolism of Inhaled Corticosteroids in Human Lung Tissue

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Nave Ruediger, Fisher Robyn, McCracken Nigel

Primary Institution: Nycomed GmbH

Hypothesis

The metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in the lung is considerably different.

Conclusion

The in vitro metabolic pathways of the tested inhaled corticosteroids in human lung tissue were differing, with fluticasone propionate being metabolically stable and the majority of beclomethasone dipropionate converted to inactive metabolites.

Supporting Evidence

  • Beclomethasone dipropionate was hydrolyzed to both active and inactive metabolites.
  • Ciclesonide was metabolized to its active form, desisobutyryl-ciclesonide.
  • Fluticasone propionate showed no detectable metabolites, indicating metabolic stability.

Takeaway

This study looked at how different asthma medications are broken down in the lungs, finding that some are more effective than others at staying active.

Methodology

Lung tissue slices were incubated with various corticosteroids, and their metabolites were analyzed using HPLC.

Potential Biases

Potential bias due to the involvement of employees from the sponsoring company in the study.

Limitations

The study used a high initial concentration of drugs that may not reflect typical clinical doses.

Participant Demographics

[{"age":19,"sex":"Male","race":"Hispanic"},{"age":48,"sex":"Male","race":"Caucasian"},{"age":43,"sex":"Female","race":"Caucasian"}]

Digital Object Identifier (DOI)

10.1186/1465-9921-8-65

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication